Tango Therapeutics to go public with $353m merger deal
Tango Therapeutics is set to go public with the signing of a definitive merger agreement with the Boxer Capital-sponsored special…
Tango Therapeutics is set to go public with the signing of a definitive merger agreement with the Boxer Capital-sponsored special…
The University of Oxford has expanded the Comparing Covid-19 Vaccine Schedule Combinations – Stage 2 (Com-COV2) study to include the…
Claritas Pharmaceuticals is set to expand its development programme for R-107 to include the treatment of Covid-19 related sepsis, which is the leading cause of…
Eli Lilly and Incyte have reported that the Phase III COV-BARRIER study of baricitinib failed to meet statistical significance on the primary endpoint of progression…
AIM ImmunoTech has reported that no serious adverse events were observed in Cohort 1 of a Phase I AMP-COV-100 (CHDR2049)…
Icosavax has raised $100m through a Series B financing round to support the development of its bivalent respiratory syncytial virus…
Sound Pharmaceuticals is all set to launch two Phase II clinical trials of an oral capsule, SPI-1005, for treating patients…
Valneva has reported that initial results from Part A of the Phase I/II clinical trial of its inactivated Covid-19 vaccine…
More than a year has passed since national lockdowns, social distancing and face masks became a regular feature of life…
Innovation Pharmaceuticals is set to increase dosing frequency in Phase II clinical trial of a drug candidate, Brilacidin, for treating…
Fujifilm Diosynth Biotechnologies (FDB), a subsidiary of Japanese multinational conglomerate Fujifilm, is expanding its large-scale biologics production facility in Hillerod,…
Targeted development processes and a variety of products set high standards in the reliability, control and security of the processes.…
Reliable process control is indispensable when freezing and thawing pharmaceutical and biotechnological products. The same applies to the adjustable freezing…